Skip to main content
. 2022 Apr 28;27(9):2823. doi: 10.3390/molecules27092823

Figure 3.

Figure 3

The overall procedure workflow used for the definition of the 3-D pharmacophore/3-D QSAR models and their analysis is depicted as a “black” pathway. The application of generated 3-D pharmacophore/3-D QSAR models in structure-based and ligand-based virtual screening is depicted as a “red” pathway.